Cadman L Leggett1, Jason T Lewis2, Tsung Teh Wu2, Cathy D Schleck3, Alan R Zinsmeister3, Kelly T Dunagan1, Lori S Lutzke1, Kenneth K Wang1, Prasad G Iyer4. 1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. 2. Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota. 3. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota. 4. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: iyer.prasad@mayo.edu.
Abstract
BACKGROUND & AIMS: Superficial (T1) esophageal adenocarcinoma (EAC) commonly is treated by endoscopic resection, yet little is known about factors that predict outcomes of this approach. We assessed clinical and histologic variables associated with the overall survival times of patients with T1 EAC who received therapy. METHODS: In a retrospective analysis, we collected data from patients who underwent endoscopic mucosal resection (EMR) for T1 EAC (194 patients with T1a and 75 patients with T1b) at the Mayo Clinic, from 1995 through 2011. EMR specimens were reviewed systematically for depth of invasion, presence of lymphovascular invasion, grade of differentiation, and status of resection margins. Kaplan-Meier curves and proportional hazards regression models were used in statistical analyses. RESULTS: Demographic characteristics were similar between patients with T1a and T1b EAC. Overall survival at 5 years after EMR was 74.4% for patients with T1a (95% confidence interval [CI], 67.6%-81.8%) and 53.2% for patients with T1b EAC (95% CI, 40.3%-70.1%). Of surviving patients with T1a EAC, 94.1% remained free of cancer (95% CI, 89.8%-98.5%), and 94.7% of surviving patients with T1b EAC remained free of cancer (95% CI, 85.2%-100%). A multivariable model associated older age (per 10-year increment), evidence of lymphovascular invasion, and deep margin involvement with reduced overall survival in patients with T1 EAC. CONCLUSIONS: Systematic assessment of EMR specimens can help predict mortality and potentially guide treatment options for patients with T1 EAC.
BACKGROUND & AIMS: Superficial (T1) esophageal adenocarcinoma (EAC) commonly is treated by endoscopic resection, yet little is known about factors that predict outcomes of this approach. We assessed clinical and histologic variables associated with the overall survival times of patients with T1 EAC who received therapy. METHODS: In a retrospective analysis, we collected data from patients who underwent endoscopic mucosal resection (EMR) for T1 EAC (194 patients with T1a and 75 patients with T1b) at the Mayo Clinic, from 1995 through 2011. EMR specimens were reviewed systematically for depth of invasion, presence of lymphovascular invasion, grade of differentiation, and status of resection margins. Kaplan-Meier curves and proportional hazards regression models were used in statistical analyses. RESULTS: Demographic characteristics were similar between patients with T1a and T1b EAC. Overall survival at 5 years after EMR was 74.4% for patients with T1a (95% confidence interval [CI], 67.6%-81.8%) and 53.2% for patients with T1b EAC (95% CI, 40.3%-70.1%). Of surviving patients with T1a EAC, 94.1% remained free of cancer (95% CI, 89.8%-98.5%), and 94.7% of surviving patients with T1b EAC remained free of cancer (95% CI, 85.2%-100%). A multivariable model associated older age (per 10-year increment), evidence of lymphovascular invasion, and deep margin involvement with reduced overall survival in patients with T1 EAC. CONCLUSIONS: Systematic assessment of EMR specimens can help predict mortality and potentially guide treatment options for patients with T1 EAC.
Authors: Lawrence Lee; Ulrich Ronellenfitsch; Wayne L Hofstetter; Gail Darling; Timo Gaiser; Christiane Lippert; Sebastien Gilbert; Andrew J Seely; David S Mulder; Lorenzo E Ferri Journal: J Am Coll Surg Date: 2013-05-06 Impact factor: 6.113
Authors: Putao Cen; Wayne L Hofstetter; Arlene M Correa; Tsung-Teh Wu; Jeffery H Lee; William A Ross; Marta Davilla; Stephen G Swisher; Norio Fukami; Asif Rashid; Dipen Maru; Jaffer A Ajani Journal: Cancer Date: 2008-03-01 Impact factor: 6.860
Authors: Arjun Pennathur; Andrew Farkas; Alyssa M Krasinskas; Peter F Ferson; William E Gooding; Michael K Gibson; Matthew J Schuchert; Rodney J Landreneau; James D Luketich Journal: Ann Thorac Surg Date: 2009-04 Impact factor: 4.330
Authors: O Pech; A Behrens; A May; L Nachbar; L Gossner; T Rabenstein; H Manner; E Guenter; J Huijsmans; M Vieth; M Stolte; C Ell Journal: Gut Date: 2008-05-06 Impact factor: 23.059
Authors: Mari Mino-Kenudson; Mindy J Hull; Ian Brown; Alona Muzikansky; Amitabh Srivastava; Jonathan Glickman; Do-Youn Park; Lawrence Zuckerberg; Joseph Misdraji; Robert D Odze; Gregory Y Lauwers Journal: Gastrointest Endosc Date: 2007-10 Impact factor: 9.427
Authors: Ganapathy A Prasad; Tsung Teh Wu; Dennis A Wigle; Navtej S Buttar; Louis-Michel Wongkeesong; Kelly T Dunagan; Lori S Lutzke; Lynn S Borkenhagen; Kenneth K Wang Journal: Gastroenterology Date: 2009-06-12 Impact factor: 22.682
Authors: D Chamil Codipilly; Apoorva Krishna Chandar; Kenneth K Wang; David A Katzka; John R Goldblum; Prashanthi N Thota; Gary W Falk; Amitabh Chak; Prasad G Iyer Journal: Gastrointest Endosc Date: 2021-09-17 Impact factor: 9.427
Authors: Fouad Otaki; Gene K Ma; Anna Krigel; Ross A Dierkhising; Jason T Lewis; Christopher H Blevins; Naveen P Gopalakrishnan; Adharsh Ravindran; Michele L Johnson; Cadman L Leggett; Denis Wigle; Kenneth K Wang; Gary W Falk; Julian A Abrams; Hiroshi Nakagawa; Anil K Rustgi; Timothy C Wang; Charles J Lightdale; Gregory G Ginsberg; Prasad G Iyer Journal: Gastrointest Endosc Date: 2020-01-15 Impact factor: 9.427
Authors: Darren D Ballard; Neel Choksi; Jingmei Lin; Eun-Young Choi; B Joseph Elmunzer; Henry Appelman; Douglas K Rex; Hala Fatima; William Kessler; John M DeWitt Journal: World J Gastrointest Endosc Date: 2016-12-16
Authors: Prasad G Iyer; William R Taylor; Michele L Johnson; Ramona L Lansing; Kristyn A Maixner; Lois L Hemminger; Frances K Cayer; Tracy C Yab; Mary E Devens; Seth W Slettedahl; Brendan T Broderick; Douglas W Mahoney; Maria C McGlinch; Calise K Berger; Patrick H Foote; Maria Giakomopoulos; Hatim Allawi; Thomas C Smyrk; Kenneth K Wang; David A Katzka; Herbert C Wolfsen; James A Burke; David A Ahlquist; John B Kisiel Journal: Am J Gastroenterol Date: 2020-08 Impact factor: 12.045